CSL - Trade Creditors


CSL reported $3.17B in Trade Creditors for its fiscal semester ending in December of 2025.





Trade Creditors Change Date
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Arca Biopharma USD 6.67M 2.5M Mar/2026
aTyr Pharma USD 2.76M 52.32M Mar/2026
Bio Path USD 5.16M 260K Mar/2026
Brainstorm Cell Therapeutics USD 7.32M 250K Mar/2026
Cara Therapeutics USD 4.62M 1.4M Mar/2026
CSL USD 3.17B 290M Dec/2025
Curis USD 6.74M 1.13M Mar/2026
Immunic USD 11.01M 873K Mar/2026
Minerva Neurosciences USD 640K 305K Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
TherapeuticsMD USD 143K 4K Jun/2024